AJP - Regu Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 291: R1376-R1382, 2006. First published June 15, 2006; doi:10.1152/ajpregu.00722.2005
0363-6119/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/5/R1376    most recent
00722.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wangensteen, R.
Right arrow Articles by Vargas, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wangensteen, R.
Right arrow Articles by Vargas, F.

NEUROHUMORAL CONTROL OF CARDIOVASCULAR FUNCTION

Effects of chronic treatment with 7-nitroindazole in hyperthyroid rats

Rosemary Wangensteen,1 Isabel Rodríguez-Gómez,2 Juan Manuel Moreno,3 Miriam Álvarez-Guerra,1 Antonio Osuna,3 and Félix Vargas2

1Departamento de Ciencias de la Salud, Universidad de Jaén, Jaén; 2Departamento de Fisiología, Facultad de Medicina, Granada; and 3Servicio de Nefrología, Unidad Experimental, Hospital Virgen de las Nieves, Granada, Spain

Submitted 11 October 2005 ; accepted in final form 31 May 2006

This study analyzed the contribution of neuronal nitric oxide synthase (nNOS) to the hemodynamic manifestations of hyperthyroidism. The effects on hyperthyroid rats of the chronic administration of 7-nitroindazole (7-NI), an inhibitor of nNOS, were studied. Six groups of male Wistar rats were used: control, 7-NI (30 mg·kg–1·day–1 by gavage), T450, T475 (50 or 75 µg thyroxine·rat–1·day–1, respectively), T450+7-NI, and T475+7-NI. All treatments were maintained for 4 wk. Body weight, tail systolic blood pressure (SBP), and heart rate (HR) were recorded weekly. Finally, SBP, pulse pressure (PP), and HR were measured in conscious rats, and morphological, metabolic, plasma, and renal variables were determined. Expression of nNOS in the hypothalamus of T475 and control rats was analyzed by Western blot analysis. The response of mean arterial pressure (MAP) to pentolinium (10 mg/kg iv) was used to evaluate the sympathetic contribution to BP in T475 and T475+7-NI rats. T4 produced an increased hypothalamic nNOS expression and dose-related increases in blood pressure (BP), HR, and PP vs. control rats. 7-NI did not modify BP or any other hemodynamic variable in normal rats. However, 7-NI produced a marked reduction in BP, HR, PP, and food and water intake in both hyperthyroid groups and improved creatinine clearance in the T475 group. Pentolinium produced a greater MAP decrease in the T475+7-NI than in the T475 group. In conclusion, administration of 7-NI attenuates the hemodynamic and metabolic manifestations of hyperthyroidism, suggesting that nNOS contributes to the hyperdynamic circulation of this endocrine disease by modulating sympathetic activity.

blood pressure; heart rate; pulse pressure; neuronal nitric oxide synthase inhibition



Address for reprint requests and other correspondence: F. Vargas, Departamento de Fisiología, Facultad de Medicina, 18012 Granada, Spain (e-mail: fvargas{at}ugr.es)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.